Cargando…
Dosage Compensation in Females with X-Linked Metabolic Disorders
Through the use of new genomic and metabolomic technologies, our comprehension of the molecular and biochemical etiologies of genetic disorders is rapidly expanding, and so are insights into their varying phenotypes. Dosage compensation (lyonization) is an epigenetic mechanism that balances the expr...
Autores principales: | Juchniewicz, Patrycja, Piotrowska, Ewa, Kloska, Anna, Podlacha, Magdalena, Mantej, Jagoda, Węgrzyn, Grzegorz, Tukaj, Stefan, Jakóbkiewicz-Banecka, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123450/ https://www.ncbi.nlm.nih.gov/pubmed/33925963 http://dx.doi.org/10.3390/ijms22094514 |
Ejemplares similares
-
X-chromosome inactivation patterns depend on age and tissue but not conception method in humans
por: Juchniewicz, Patrycja, et al.
Publicado: (2023) -
Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
por: Kloska, Anna, et al.
Publicado: (2011) -
Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2009) -
Synthetic genistein derivatives as modulators of glycosaminoglycan storage
por: Kloska, Anna, et al.
Publicado: (2012) -
The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis
por: Moskot, Marta, et al.
Publicado: (2019)